Highlights of Past EHA (HOPE) EMEA 2020

TSH Logo enEHA and the Turkish Society of Hematology are very happy to announce that the first virtual Highlights of Past EHA will take place on October 9 and 10, 2020. The program will bring a broad range of topics from the EHA25 Virtual Congress to the hematology community in Turkey, the Middle East, North Africa and the Balkan region. Registration will open soon for this exciting virtual program bringing the EHA congress updates to your own screen.

Registration page:


About the program

The format of the program has been completely transformed and will be comprised of update presentations in the various fields of hematology, followed by break-out sessions with experts on specific topics. The new format will focus on the interaction between the speakers and the participants by creating space for questions and discussion. In addition, there will be key note lectures deepening your knowledge on specific topics.
The main topics of the program are as follows:

  • Acute myeloid leukemia
  • Myelodysplastic syndromes
  • Plasma cell disorders
  • Myeloproliferative neoplasms
  • Lymphoproliferative disorders
  • Benign hematology
  • Hemoglobinopathies
  • CAR-T cell therapy

Target audience

The main focus of this highlights program are (general) hematologists, clinicians, scientists or trainees, from Turkey and the Balkan countries, the Middle East, and North Africa.

Participants from other countries are also welcome, but dedicated HOPE Meetings are in preparation for Latin America and Asia, and the details can be found on the main meeting page here.


Are you interested to support this interesting virtual program, then please don’t hesitate to contact sponsorship@ehaweb.org.

EBAH CME accreditation

This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.



14:00 - 14:15 Opening ceremony

Hayri Özsan (TR), John Gribben (UK)

14:15 – 15:30 Session 1: AML

  • Overview Presentation 1
    Update on AML
    K Döhner (DE)
  • Expert break-outs
    Down syndrome in AML
    S Izraeli (IL)
    Treatment of pediatric AML
    GJ Kaspers (NL)

15:30 – 15:45 A moment to stretch & relax

15:45 – 17:00 Session 2: MDS

  • Overview Presentation 2
    Update on MDS
    P Fenaux (FR)
  • Expert break-outs
    Germline mutations and risk of bone marrow failure and MDS J Soulier (FR)
    Understanding the pathophysiology: Risk based treatment of MDS in 2020
    A Almeida (PT)

15:30 – 15:45 A moment to stretch & relax

15:45 – 17:00 Session 3: Plasma cell disorders

  • Overview Presentation 3
    Update on diagnosis and treatment of multiple myeloma
    M Dimopoulos (GR)
  • Expert break-outs
    Diagnosis and current management of AL amyloidosis G Palladini (IT)
    Diagnosis and treatment of high risk MM: Update 2020 (incl. immunotherapies)
    M Cavo (IT)

19:00 – 19:15  Close of Day 1

09:00 Opening day 2

09:00 – 09:30 Keynote Lecture 1

  • CAR T cells in 2020
    A Urbano-Ispizua (ES)

09:30 – 10:45 Session 2: Myeloproliferative neoplasms

  • Overview Presentation 4
    Update on MPN
    A Almeida (PT)
  • Expert break-outs
    Current standards in the diagnosis and treatment of mastocytosis
    J Ungerstedt (SE)
    Challenges in SCT in myelofibrosis
    E Ollavaria (UK)

10:45 – 11:00 A moment to stretch & relax

11:00 – 12:15 Session 5: Lymphoproliferative disorders

  • Overview Presentation 5
    Update on lymphoma
    G Gaidano (IT)
  • Expert break-outs
    Molecular classification and treatment of aggressive B-cell lymphomas
    A Davies (UK)
  • Molecular classification and biomarker driven therapies in T-cell lymphomas
    R Koch (DE)

12:15 – 13:15  Time for Lunch!

12:15 – 12:45 Amgen Satellite Symposium

  • Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia
  •  Chair: Osman İlhan (TR)
  • Speaker: Ali İrfan Emre Tekgündüz (TR)

13:15 – 13:45 Keynote Lecture 2

  • CLL
    J Gribben (UK)

13:45 – 15:00 Session 6: Benign hematology

  • Overview Presentation 6
    Update on VTE
    Reyhan Diz Küçükkaya
  • Expert break-outs
    TTP versus HUS: Understanding the disease
    Marie Scully (UK)
    Current understanding and management of DIC
    CH Toh (UK)

15:00 – 15:15 A moment to stretch & relax

15:15 – 16:00 EHA-TSH Joint Symposium

  • Iron Overload and Monitoring in Hemoglobinopathies
    Şule Ünal Cangül (TR)

16:00 Closing Remarks